Article
Intensification of treatment with pegylated interferon alfa in patients coinfected with HIV and HBV genotype H or G being treated with a tenofovir/emtricitabine-containing regimen.
Hepato-gastroenterology - 1 Jan 2000
Mata-Marín José Antonio, Mata-Marín Luis Alberto, Arroyo-Anduiza Carla Ileana, Huerta-García Gloria, Sandoval-Ramirez J L, Manjarrez-Tellez Bulmaro, Gaytán-Martínez J E
Abstract excerpt
BACKGROUND/AIMS: The most common HBV genotypes in HIV-coinfected patients in Mexico are H and G; the response to treatment for these genotypes is unknown. The aim of the study was to examine the effectiveness of intensification with pegylated interferon (PEG-IFN) alfa-2a or alfa-2b in HBV/HIV-coinfected patients treated with a tenofovir/emtricitabine (TDF/FTC) backbone in an HIV clinic in Mexico City....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.